Exposure-Eusol treatment for burn wounds.
Data from 45 adult patients with flame burns covering up to 20 per cent EAB (Group 1), 21-40 per cent (Group 2), and 41-60 per cent (Group 3) are presented. Each group contains 15 patients with 29 females and 16 males, and females had the more extensive burns. All the patients were treated by the exposure method followed by Eusol dressings beginning between post burn days 5 and 7, i.e. as soon as infection was detected or the eschar had started separating. Eusol is an effective antibacterial agent and also assists in slough separation. It appears to be inactive against living tissues and helps obtain healthy granulation tissue. The bed thus created is ideal for grafting. A burn wound up to 40 per cent EAB is suitable for treatment by the exposure-Eusol method. Septicaemia was the common cause of mortality and its incidence was directly related to the extent of injury.
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001881:Borates; D002056:Burns / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D016038:Skin Transplantation; D012973:Sodium Hypochlorite
D000890:Anti-Infective Agents; D001881:Borates; C024611:Eusol; D012973:Sodium Hypochlorite